Toll-like receptor 9 agonists promote IL-8 and TGF-β1production via activation of nuclear factor κB in PC-3 cells

Cancer Genetics and Cytogenetics

Volumn 192, Issue 2, 2009, Pages 60-67

  Di, Jin ming ^a   Pang, Jun ^a   Pu, Xiao yong ^a   Zhang, Yan ^a   Liu, Xiao peng ^a   Fang, You qiang ^a   Ruan, Xing xing ^a   Gao, Xin ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CPG OLIGODEOXYNUCLEOTIDE; CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 8; TOLL LIKE RECEPTOR 9; TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; CELL ACTIVATION; CELL STRAIN; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME ACTIVATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION;

CELL LINE, TUMOR; CELL NUCLEUS; CHLOROQUINE; HUMANS; INTERLEUKIN-8; MALE; NF-KAPPA B; OLIGODEOXYRIBONUCLEOTIDES; PROLINE; PROSTATIC NEOPLASMS; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION; THIOCARBAMATES; TOLL-LIKE RECEPTOR 9; TRANSFORMING GROWTH FACTOR BETA1;

EID: 67649777060     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2009.03.006     Document Type: Article

References (34)

1. Sarma A.V., McLaughlin J.C., Wallner L.P., Dunn R.L., Cooney K.A., Schottenfeld D., Montie J.E., and Wei J.T. Sexual behavior, sexually transmitted diseases and prostatitis: the risk of prostate cancer in black men. J Urol 176 (2006) 1108-1113
2. Urisman A., Molinaro R.J., Fischer N., Plummer S.J., Casey G., Klein E.A., Malathi K., Magi-Galluzzi C., Tubbs R.R., Ganem D., Silverman R.H., and DeRisi J.L. Identification of a novel Gammaretrovirus in prostate tumors of patients homozygous for R462Q RNASEL variant. PLoS Pathog 2 (2006) e25
3. Elkahwaji J.E., Zhong W., Hopkins W.J., and Bushman W. Chronic bacterial infection and inflammation incite reactive hyperplasia in a mouse model of chronic prostatitis. Prostate 67 (2007) 14-21
4. Coussens L.M., and Werb Z. Inflammation and cancer. Nature 420 (2002) 860-867
5. Irani J., Goujon J.M., Ragni E., Peyrat L., Hubert J., Saint F., and Mottet N. Pathologist Multi Center Study Group. High-grade inflammation in prostate cancer as a prognostic factor for biochemical recurrence after radical prostatectomy. Urology 54 (1999) 467-472
6. Ilvesaro J.M., Merrell M.A., Swain T.M., Davidson J., Zayzafoon M., Harris K.W., and Selander K.S. Toll like receptor-9 agonists stimulate prostate cancer invasion in vitro. Prostate 67 (2007) 774-781
7. He W., Liu Q., Wang L., Chen W., Li N., and Cao X. Tlr4 signaling promotes immune escape of human lung cancer cells by inducing immunosuppressive cytokines and apoptosis resistance. Mol Immunol 44 (2007) 2850-2859
8. Lu S., and Dong Z. Characterization of TGF-β-regulated interleukin-8 expression in human prostate cancer cells. Prostate 66 (2006) 996-1004
9. Yuan A., Yang P.C., Yu C.J., Chen W.J., Lin F.Y., Kuo S.H., and Luh K.T. Interleukin-8 messenger ribonucleic acid expression correlates with tumor progression, tumor angiogenesis, patient survival, and timing of relapse in non-small-cell lung cancer. Am J Respir Crit Care Med 162 (2000) 1957-1963
10. Moore B.B., Arenberg D.A., Stoy K., Morgan T., Addison C.L., Morris S.B., Glass M., Wilke C., Xue Y.Y., Sitterding S., Kunkel S.L., Burdick M.D., and Strieter R.M. Distinct CXC chemokines mediate tumorigenicity of prostate cancer cells. Am J Pathol 154 (1999) 1503-1512
11. Torre-Amione G., Beauchamp R.D., Koeppen H., Park B.H., Schreiber H., Moses H.L., and Rowley D.A. A highly immunogenic tumor transfected with a murine transforming growth factor type β1 cDNA escapes immune surveillance. Proc Natl Acad Sci U S A 87 (1990) 1486-1490
12. Tuxhorn J.A., McAlhany S.J., Yang F., Dang T.D., and Rowley D.R. Inhibition of transforming growth factor-β activity decreases angiogenesis in a human prostate cancer-reactive stroma xenograft model. Cancer Res 62 (2002) 6021-6025
13. Klinman D., Shirota H., Tross D., Sato T., and Klaschik S. Synthetic oligonucleotides as modulators of inflammation. J Leukoc Biol 84 (2008) 958-964
14. Hanten J.A., Vasilakos J.P., Riter C.L., Neys L., Lipson K.E., Alkan S.S., and Birmachu W. Comparison of human B cell activation by TLR7 and TLR9 agonists. BMC Immunol 9 (2008) 39
15. József L., Khreiss T., El Kebir D., and Filep J.G. Activation of TLR-9 induces il-8 secretion through peroxynitrite signaling in human neutrophils. J Immunol 176 (2006) 1195-1202
16. Schmausser B., Andrulis M., Endrich S., Müller-Hermelink H.K., and Eck M. Toll-like receptors TLR4, TLR5 and TLR9 on gastric carcinoma cells: an implication for interaction with Helicobacter pylori. Int J Med Microbiol 295 (2005) 179-185
17. Ren T., Wen Z.K., Liu Z.M., Liang Y.J., Guo Z.L., and Xu L. Functional expression of TLR9 is associated to the metastatic potential of human lung cancer cell: functional active role of TLR9 on tumor metastasis. Cancer Biol Ther 6 (2007) 1704-1709
18. Chang Y.J., Wu M.S., Lin J.T., and Chen C.C. Helicobacter pylori-induced invasion and angiogenesis of gastric cells is mediated by cyclooxygenase-2 induction through TLR2/TLR9 and promoter regulation. J Immunol 175 (2005) 8242-8252
19. Jego G., Bataille R., Geffroy-Luseau A., Descamps G., and Pellat-Deceunynck C. Pathogen-associated molecular patterns are growth and survival factors for human myeloma cells through Toll-like receptors. Leukemia 20 (2006) 1130-1137
20. -ΔΔCt method. Methods 25 (2001) 402-408
21. Uehara H., Troncoso P., Johnston D., Bucana C.D., Dinney C., Dong Z., Fidler I.J., and Pettaway C.A. Expression of interleukin-8 gene in radical prostatectomy specimens is associated with advanced pathologic stage. Prostate 64 (2005) 40-49
22. Kumano M., Miyake H., Kurahashi T., Yamanaka K., and Fujisawa M. Enhanced progression of human prostate cancer PC3 cells induced by the microenvironment of the seminal vesicle. Br J Cancer 98 (2008) 356-362
23. Macfarlane D.E., and Manzel L. Antagonism of immunostimulatory CpG-oligodeoxynucleotides by quinacrine, chloroquine, and structurally related compounds. J Immunol 160 (1998) 1122-1131
24. Hanten J.A., Vasilakos J.P., Riter C.L., Neys L., Lipson K.E., Alkan S.S., and Birmachu W. Comparison of human B cell activation by TLR7 and TLR9 agonists. BMC Immunol 9 (2008) 39
25. Qiao B., Li B., Yang X., Zhang H., Chu Y., Wang Y., and Xiong S. Specific siRNA downregulated TLR9 and altered cytokine expression pattern in macrophage after CpG DNA stimulation. Cell Mol Immunol 2 (2005) 130-135
26. Klinman D.M. Use of CpG oligodeoxynucleotides as immunoprotective agents. Expert Opin Biol Ther 4 (2004) 937-946
27. Kundu S.D., Lee C., Billips B.K., Habermacher G.M., Zhang Q., Liu V., Wong L.Y., Klumpp D.J., and Thumbikat P. The Toll-like receptor pathway: a novel mechanism of infection-induced carcinogenesis of prostate epithelial cells. Prostate 68 (2008) 223-229
28. Merrell M.A., Ilvesaro J.M., Lehtonen N., Sorsa T., Gehrs B., Rosenthal E., Chen D., Shackley B., Harris K.W., and Selander K.S. Toll-like receptor 9 agonists promote cellular invasion by increasing matrix metalloproteinase activity. Mol Cancer Res 4 (2006) 437-447
29. Coussens L.M., and Werb Z. Inflammatory cells and cancer: think different!. J Exp Med 193 (2001) F23-F26
30. Morré D.J., and Morre D.M. tNOX, an alternative target to COX-2 to explain the anticancer activities of non-steroidal anti-inflammatory drugs (NSAIDS). Mol Cell Biochem 283 (2006) 159-167
31. López J.M., Fernández M.A., Piqué M., and Gil J. Aspirin-induced apoptosis in Jurkat cells is not mediated by peroxisome proliferator-activated receptor delta. Mol Cell Biochem 266 (2004) 57-63
32. Takeshita F., Suzuki K., Sasaki S., Ishii N., Klinman D.M., and Ishii K.J. Transcriptional regulation of the human TLR9 gene. J Immunol 173 (2004) 2552-2561
33. Bernard M.P., and Phipps R.P. CpG oligodeoxynucleotides induce cyclooxygenase-2 in human B lymphocytes: implications for adjuvant activity and antibody production. Clin Immunol 125 (2007) 138-148
34. Shen W., Waldschmidt M., Zhao X., Ratliff T., and Krieg A.M. Antitumor mechanisms of oligodeoxynucleotides with CpG and polyG motifs in murine prostate cancer cells: decrease of NF-κB and AP-1 binding activities and induction of apoptosis. Antisense Nucleic Acid Drug Dev 12 (2002) 155-164